1-3 of 3
Thomas Larsen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD19 expression is preserved following CD19-directed monoclonal antibody therapy with tafasitamab

Free
Johannes Duell, Diana Alvarez Arias, Wolfram Klapper, Sarah Reinke, Florian Eisele, Thomas Larsen, Prof. Dr. Max S Topp, Beth Rumberger, TaeHyung (Simon) Kim, Andreas Rosenwald, Hilka Rauert-Wunderlich
Journal: Blood
Blood (2025) 146 (Supplement 1): 5515.
https://doi.org/10.1182/blood-2025-5515
Published: 2025
Journal Articles

Glofitamab in combination with polatuzumab vedotin demonstrates high and durable efficacy in patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) in the second-line (2L) and third-line and later (3L+) settings: A subgroup analysis

Free
Martin Hutchings, Anna Sureda Balarí, Francesc Bosch Albareda, Thomas Larsen, Paolo Corradini, Abraham Avigdor, Maria Jose Terol, Antonio Rueda Dominguez, Antonio Pinto, Alan Skarbnik, Raul Cordoba, Judit Jørgensen, Pier Luigi Zinzani, Ronit Gurion, Neta Goldschmidt, Wilfred Leung, Donghang Li, James Relf, Martine Joanna Kallemeijn, Gila Sellam, Giuseppe Gritti
Journal: Blood
Blood (2025) 146 (Supplement 1): 5510.
https://doi.org/10.1182/blood-2025-5510
Published: 2025
Journal Articles

Challenges in comparing outcomes of frontline clinical trials for diffuse large B-cell lymphoma patients selected based on the international prognostic index: A real-world analysis from the danish lymphoma registry

Free
Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Rasmus Rask Kragh Jørgensen, Mikkel Runason Simonsen, Michael Roost Clausen, Ahmed Al-Mashhadi, Robert Pedersen, Christian Poulsen, Anne Ortved Gang, Peter Brown, Tarec Christoffer El-Galaly, Thomas Larsen
Journal: Blood
Blood (2025) 146 (Supplement 1): 896.
https://doi.org/10.1182/blood-2025-896
Published: 2025